2026-10-19T01:06:20Zhttps://ebyu-rdlopen.rawdatalibrary.net/oai/request

oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/114602026-10-18T21:13:14Zopenairedrivercom_ebyu_10000col_ebyu_10001

Corrigendum to “Forecasting of Oxidant/Antioxidant levels of COVID-19 patients by using Expert models with biomarkers used in the Diagnosis/Prognosis of COVID-19” [Int. Immunopharmacol. 100 (2021) 108127] (International Immunopharmacology (2021) 100, (S1567576921007633), (10.1016/j.intimp.2021.108127))Huyut, Mehmet TahirHuyut, Zübeyirerratumhumanmiddle ageddrug developmentnonhumanpharmacologyThe author regrets that the following ethical approval number is missing from the article: 27/06/2021, Ref. No. 11-13. The authors would like to apologise for any inconvenience caused. © 2024 Elsevier B.V.Elsevier B.V.2024Correctionhttps://rdlopen.rawdatalibrary.net/r/ebyu/11460https://doi.org/10.1016/j.intimp.2024.1136501567-5769enInternational Immunopharmacologyinfo:eu-repo/semantics/openAccessinfo:eu-repo/semantics/articlehttps://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/11460